Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Prospective Study to Evaluate the Safety and Efficacy of Double or Triple Concentrated Intravenous Nicardipine for Treatment of Hypertension in Patients With Ischemic Stroke, Intracerebral Hemorrhage or Subarachnoid Hemorrhage

NCT00325793 is registered in ClinicalTrials.gov with OSF Healthcare System as lead sponsor.

NCT NCT00325793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00325793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Prospective Study to Evaluate the Safety and Efficacy of Double or Triple Concentrated Intravenous Nicardipine for Treatment of Hypertension in Patients With Ischemic Stroke, Intracerebral Hemorrhage or Subarachnoid Hemorrhage
Lead sponsor
OSF Healthcare System
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2004
Completion date
Not reported
Enrollment
50
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension